BioArctic Investor Relations Material
Latest events
Q4 2024
BioArctic
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from BioArctic
Access all reports
Segment Data
Access more data
Net revenue by
Geography
Asia
Europe
Expenses by
Financials
BioArctic AB is a research intensive biopharmaceutical company focusing on disease modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. BioArctic focuses on innovative treatments in areas with high unmet medical needs. The company was founded in 1993 based on scientific research from Uppsala University, Sweden. Collaborations with universities are of great importance to the company together with our strategically important global partners in the Alzheimer and Parkinson projects.
Key slides for BioArctic
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
BIOA
Country
🇸🇪 Sweden